113 related articles for article (PubMed ID: 22030867)
1. Production of L1 protein from different types of HPV in Pichia pastoris using an integrative vector.
Coimbra EC; Gomes FB; Campos JF; D'arc M; Carvalho JC; Mariz FC; Jesus AL; Stocco RC; Beçak W; Freitas AC
Braz J Med Biol Res; 2011 Dec; 44(12):1209-14. PubMed ID: 22030867
[TBL] [Abstract][Full Text] [Related]
2. Whole recombinant Pichia pastoris expressing HPV16 L1 antigen is superior in inducing protection against tumor growth as compared to killed transgenic Leishmania.
Bolhassani A; Muller M; Roohvand F; Motevalli F; Agi E; Shokri M; Rad MM; Hosseinzadeh S
Hum Vaccin Immunother; 2014; 10(12):3499-508. PubMed ID: 25668661
[TBL] [Abstract][Full Text] [Related]
3. Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris.
Bazan SB; de Alencar Muniz Chaves A; Aires KA; Cianciarullo AM; Garcea RL; Ho PL
Arch Virol; 2009; 154(10):1609-17. PubMed ID: 19756360
[TBL] [Abstract][Full Text] [Related]
4. VLP Production from Recombinant L1/L2 HPV-16 Protein Expressed in Pichia Pastoris.
Sanchooli A; Aghaiypour K; Kiasari BA; Samarbaf-Zadeh A; Ghadiri A; Makvandi M
Protein Pept Lett; 2018; 25(8):783-790. PubMed ID: 30091403
[TBL] [Abstract][Full Text] [Related]
5. Purification and immunogenicity study of human papillomavirus 58 virus-like particles expressed in Pichia pastoris.
Jiang Z; Tong G; Cai B; Xu Y; Lou J
Protein Expr Purif; 2011 Dec; 80(2):203-10. PubMed ID: 21821128
[TBL] [Abstract][Full Text] [Related]
6. Expression of unique chimeric human papilloma virus type 16 (HPV-16) L1-L2 proteins in Pichia pastoris and Hansenula polymorpha.
Bredell H; Smith JJ; Görgens JF; van Zyl WH
Yeast; 2018 Sep; 35(9):519-529. PubMed ID: 29709079
[TBL] [Abstract][Full Text] [Related]
7. Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles.
Hanumantha Rao N; Baji Babu P; Rajendra L; Sriraman R; Pang YY; Schiller JT; Srinivasan VA
Vaccine; 2011 Oct; 29(43):7326-34. PubMed ID: 21803095
[TBL] [Abstract][Full Text] [Related]
8. [Gene optimization is necessary to express HPV type 6 L1 protein in the methylotrophic yeast Pichia pastoris].
Li PC; Zhang XG; Zhou L; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Dec; 17(4):310-4. PubMed ID: 15340539
[TBL] [Abstract][Full Text] [Related]
9. Expression of the bovine papillomavirus type 1, 2 and 4 L1 genes in the yeast Pichia pastoris.
Jesus AL; Mariz FC; Souza HM; Cordeiro MN; Coimbra EC; Leitão MC; Nascimento LM; Stocco RC; Beçak W; Freitas AC
Genet Mol Res; 2012 Aug; 11(3):2598-607. PubMed ID: 22869085
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical characterization and immunological properties of Pichia pastoris based HPV16L1 and 18L1 virus like particles.
Gupta G; Glueck R; Rishi N
Biologicals; 2017 Mar; 46():11-22. PubMed ID: 28012703
[TBL] [Abstract][Full Text] [Related]
11. Development of an IP-Free Biotechnology Platform for Constitutive Production of HPV16 L1 Capsid Protein Using the Pichia pastoris PGK1 Promoter.
Mariz FC; Coimbra EC; Jesus AL; Nascimento LM; Torres FA; Freitas AC
Biomed Res Int; 2015; 2015():594120. PubMed ID: 26090426
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a panARS-based episomal vector in the methylotrophic yeast Pichia pastoris for recombinant protein production and synthetic biology applications.
Camattari A; Goh A; Yip LY; Tan AH; Ng SW; Tran A; Liu G; Liachko I; Dunham MJ; Rancati G
Microb Cell Fact; 2016 Aug; 15(1):139. PubMed ID: 27515025
[TBL] [Abstract][Full Text] [Related]
13. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of next-generation HPV vaccines in non-human primates: Measles-vectored HPV vaccine versus Pichia pastoris recombinant protein vaccine.
Gupta G; Giannino V; Rishi N; Glueck R
Vaccine; 2016 Sep; 34(39):4724-4731. PubMed ID: 27523740
[TBL] [Abstract][Full Text] [Related]
15. Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine.
Hassan SW; Waheed MT; Müller M; Clarke JL; Shinwari ZK; Lössl AG
Hum Vaccin Immunother; 2014; 10(10):2975-82. PubMed ID: 25483463
[TBL] [Abstract][Full Text] [Related]
16. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
17. Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras.
Pineo CB; Hitzeroth II; Rybicki EP
Plant Biotechnol J; 2013 Oct; 11(8):964-75. PubMed ID: 23924054
[TBL] [Abstract][Full Text] [Related]
18. Effective Neutralizing Antibody Produced in Mice Directly Immunized with Integrated
Xv Z; Lv J; Jiang J; Wang W; Feng F; Zhang L; Xue X; Li W
Viral Immunol; 2019 Sep; 32(7):308-317. PubMed ID: 31381497
[TBL] [Abstract][Full Text] [Related]
19. Production of codon-optimized
Dewi KS; Chairunnisa S; Swasthikawati S; Yuliawati ; Agustiyanti DF; Mustopa AZ; Kusharyoto W; Ningrum RA
Prep Biochem Biotechnol; 2023; 53(2):148-156. PubMed ID: 35302435
[TBL] [Abstract][Full Text] [Related]
20. Production of immunogenic human papillomavirus-16 major capsid protein derived virus like particles.
Patel MC; Patkar KK; Basu A; Mohandas KM; Mukhopadhyaya R
Indian J Med Res; 2009 Sep; 130(3):213-8. PubMed ID: 19901429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]